海正生材股价涨5.06%，广发基金旗下1只基金位居十大流通股东，持有704.78万股浮盈赚取577.92万元

Company Overview - Zhejiang Haizheng Biomaterials Co., Ltd. is located in Taizhou Bay New District, Zhejiang Province, and was established on August 26, 2004. The company went public on August 16, 2022. Its main business involves the research, production, and sales of polylactic acid (PLA) [1] - The revenue composition of the company includes 78.55% from pure polylactic acid, 20.50% from modified polylactic acid, and 0.96% from other sources [1] Stock Performance - On September 8, Haizheng Biomaterials' stock rose by 5.06%, reaching a price of 17.02 yuan per share, with a trading volume of 110 million yuan and a turnover rate of 5.61%. The total market capitalization is 3.45 billion yuan [1] Shareholder Information - According to data, one of the top ten circulating shareholders of Haizheng Biomaterials is the Guangfa Technology Innovation Mixed Fund A (008638), which entered the top ten in the second quarter with 7.05 million shares, accounting for 5.99% of the circulating shares. The estimated floating profit today is approximately 5.78 million yuan [2] - Guangfa Technology Innovation Mixed Fund A was established on December 25, 2019, with a latest scale of 2.657 billion yuan. Year-to-date returns are 42.42%, ranking 1002 out of 8248 in its category; the one-year return is 79.57%, ranking 755 out of 8051; and since inception, the return is 121.36% [2]